Evaluation of the Effect of Robot-assisted Early Mobilization - Project MobiStaR (MobiStaR)

October 10, 2023 updated by: Dr. Uli Fischer, Ludwig-Maximilians - University of Munich

Evaluation of the Effect of Robot-assisted Early Mobilization on Critically Ill Patients, on the Mobilisation Behaviour and Experience of Mobilizing Professionals and Organisational Processes in an Intensive Care Unit

Within the MobiStaR project the adaptation of procedures in an intensive care unit combined with the use of this robotic system will create the conditions to increase the mobilization rate of critically ill intensive care patients significantly, possibly thereby increasing the rehabilitation outcomes for these patients and developing a new standard of care for robot-assisted early mobilization.

The intervention study will assess the organizational feasibility of robot-assisted early mobilization (starting in the first 72 hours after admission to the ICU), the behavior and experience of the mobilizing professionals and the effects on patient outcomes in terms of ventilation time, muscle mass (sonographic examination) and physical activity (measured by established scores such as Functional Status Score for ICU (FSS-ICU) and Medical Research Council (MRC) classification).

Study Overview

Status

Completed

Detailed Description

Early mobilization means the mobilization of critically ill patients in the early course after admission to the intensive care unit. The positive influence of early mobilization of critically ill patients on various aspects of patient outcomes has already been demonstrated. However, the implementation of early mobilization in clinical practice is difficult. Especially the high personnel effort is a barrier.

The Munich-based company Reactive Robotics (RR) is currently developing the world's first adaptive robotic assistance system VEMO©, which has CE approval for the planned indication and is to be used in the medium term for mobilizing intensive care patients.

Within the MobiStaR project, the adaptation of procedures in an intensive care unit combined with the use of this robotic system will create the conditions to significantly increase the mobilization rate of critically ill intensive care patients, possibly thereby increasing the rehabilitation results for these patients and developing a new standard of care for robot-assisted early mobilization. In this project, the robotic system will be used in anesthesiology intensive care units of the Ludwigs-Maximilians-University hospital.

Within this study, the effects of robot-assisted early mobilization will now be evaluated. This study comprises three study arms, in which (1) the feasibility and practicability of robot-assisted early mobilization, (2) the behavior and experience of the mobilizing professionals, and (3) the effect on patient outcomes will be evaluated.

The study is monocentric, prospective, interventional, does not include invasive procedures or blood sampling and has multiple data collection time points.

  1. The feasibility of robot-assisted early mobilization surveys concomitantly how many VEM therapies can be implemented in how many patients as well as if and which adverse events occur.
  2. The behavior and experience of the mobilizing professionals will be evaluated by using episodic interviews and standardized observations. Nurses with advanced training in anesthesia and intensive care, nurses and physiotherapists who have at least three years of professional experience in an intensive care unit as well as medical specialists with completed specialist training or a leading position in the intensive care unit will be included.
  3. The effects on patient outcomes, primarily ventilation duration, muscle mass (sonographic examination) and physical activity (measured by established scores such as FSS-ICU and MRC classification), will be measured at different time points and compared with a historical patient population. Secondary factors such as delirium incidence, hemodynamic parameters, respiratory parameters but also longitudinal parameters such as ICU and hospital length of stay will be analyzed from routine data/patient records. Informed consenting patients undergoing a planned surgical procedure that is postoperatively associated with intensive care treatment and an anticipated duration of ventilation of more than 48 hours will be included. These patients will receive standardized early mobilization using the robotic system at either ten frequencies or for seven days. No invasive procedures such as blood sampling will be performed as part of the study. Outcomes will be compared with a historical comparison group to evaluate the effect of robot-assisted VEM (very early mobilization). Approximately 30 patients will be included. The outcomes will be compared with those of a historical group (n=30) treated with conventional early mobilization.

The intervention is planned for a duration of five to six months starting in September 2021.

Study Type

Interventional

Enrollment (Actual)

23

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • BY
      • Munich, BY, Germany, 81337
        • LudwigMaximilians

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • planned surgical intervention
  • postoperative intensive medical and therapeutic treatment
  • expected duration of ventilation > 48 hours
  • age ≥ 18 years
  • preoperative informed consent by the patients in the study
  • weight >45 kg and <135 kg
  • body height >1.50 m and <1.95 m

Exclusion Criteria:

  • patient refusal to participate in the study
  • unable to give consent
  • chronically bedridden before inclusion
  • clinical Frailty Scale ≥ 7
  • chronic ventilation (over 24h) before ICU admission
  • increased intracranial pressure / risk for increased intracranial pressure / recent cerebral hemorrhage
  • pregnancy
  • pre-existing neuromuscular disease resulting in chronic limitation of strength and efficiency
  • sternotomy / sternectomy during surgical procedure

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Non-Randomized
  • Interventional Model: Sequential Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: patients with robot-assisted early mobilization
All patients will receive a physical examination at various time points to assess physical functionality and muscle strength, as well as a sonographic examination of leg muscles, diaphragm, and lungs. These examinations should be performed on day -1 (preoperatively), on postoperative days 1,2,3, then once a week if the patient remains in the ICU, on day 28, on the day of discharge from the ICU, and on a follow-up examination approximately 3 months after discharge from the ICU.The follow-up examination should only take place if the patients present themselves at the hospital anyway due to medically indicated follow-up examinations (not study-related). Alternatively, patients can be asked about their condition by telephone.
The robot used for early mobilization is able to verticalize the patients in their bed without transfer and to generate a movement of the legs that measures and supports the patients' own movement. The device meets the requirements for mobilizing critically ill patients in an intensive care unit, maintaining hygiene standards and providing the best possible support for the patient's own movement.
No Intervention: patients with conventional early mobilization (historic group)
All patients fulfill the same criteria like the intervention group and receive conventional early mobilization.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Evaluation of the effect of robot-assisted early mobilization on critically ill patients - Ventilation duration
Time Frame: 6 months
changes in ventilation duration (in hours) in comparison to a historical patient group
6 months
Evaluation of the effect of robot-assisted early mobilization on critically ill patients - sonographic examination Area of the M.rec.femoris
Time Frame: 6 months
muscle mass (sonographic examination, in millimeters): Area of the M. rec. femoris in comparison to a historical patient group (in cm²)
6 months
Evaluation of the effect of robot-assisted early mobilization on critically ill patients - sonographic examination thickness M. quad. femoris
Time Frame: 6 months
muscle mass: Thickness M. quad. Femoris (in cm²) in comparison to a historical patient group
6 months
Evaluation of the effect of robot-assisted early mobilization on critically ill patients - sonographic examination- motility diaphragm breathing
Time Frame: 6 months
muscle mass: motility of the diaphragm during breathing (in cm) in comparison to a historical patient group
6 months
Evaluation of the effect of robot-assisted early mobilization on critically ill patients - sonographic examination thickness diaphragm inspiration
Time Frame: 6 months
muscle mass: Thickness of diaphragm during inspiration (in cm) in comparison to a historical patient group
6 months
Evaluation of the effect of robot-assisted early mobilization on critically ill patients - sonographic examination thickness diaphragm exhalation
Time Frame: 6 months
muscle mass: Thickness of diaphragm during exhalation (in cm) in comparison to a historical patient group
6 months
Evaluation of the effect of robot-assisted early mobilization on critically ill patients - physical activity - FSS-ICU
Time Frame: 6 months
physical activity measured using the score FSS-ICU (0 -35) in comparison to a historical patient group. A higher value means a better outcome.
6 months
Evaluation of the effect of robot-assisted early mobilization on critically ill patients - physical activity
Time Frame: 6 months
physical activity on upper and lower extremity measured using the Medical Research Council (MRC) score in comparison to a historical patient group. (0=absent muscle contraction, 1=visible muscle contraction, 2=movement when gravity is eliminated, 3=active movement against gravity, 4=active movement against resistance, 5=normal strength.)
6 months
Behavior and experience of the mobilizing professionals - qualitative interviews
Time Frame: 6 months
subjectively experienced emotions, motivating and challenging factors - evaluated with a semi-structured interview guideline
6 months
Behavior and experience of the mobilizing professionals - qualitative observations
Time Frame: 6 months
behavior and body posture during the mobilization - evaluated with a standardized observation sheet
6 months
Feasibility in organizational processes - eligible patients
Time Frame: 6 months
Frequency of eligible patients (count per week: included patients in the study/ new eligible patients in the ICUs)
6 months
Feasibility in organizational processes - mobilizations
Time Frame: 6 months
frequency of robot-assisted mobilizations (per patient per day)
6 months
Feasibility in organizational processes - adverse events
Time Frame: 6 months
adverse events (count of patient-related, user-related or technology-related adverse events)
6 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Delir
Time Frame: 6 months
Delir incidence using the CAM ICU: number of days without Delir. 1 = pathological; 2 = normal; 3 = not performed in comparison to a historical patient group
6 months
Consciousness
Time Frame: 6 months
level of consciousness using the Glasgow Coma Scale (3-15) in comparison to a historical patient group
6 months
Sedation level
Time Frame: 6 months
Sedation level using the Richmond Agitation Sedation Scale (RASS) (-5 - +5) in comparison to a historical patient group
6 months
Pain (VAS)
Time Frame: 6 months
Pain - with the use of the Visual Analog Scale (VAS) (before and after mobilization) (0-10) in comparison to a historical patient group
6 months
health related quality of life
Time Frame: 6 months
Health-related quality of life after 3 months using the the SF-36 (Short form questionnaire) (0-100) in comparison to a historical patient group
6 months
Blood pressure
Time Frame: 6 months
hemodynamics - Blood pressure (in mmHg) in comparison to a historical patient group
6 months
catecholamine demand
Time Frame: 6 months
hemodynamics - catecholamine demand (cumulative over 24 hours) in comparison to a historical patient group
6 months
heart rate
Time Frame: 6 months
hemodynamics - heart rate (1/min) in comparison to a historical patient group
6 months
cardiac output
Time Frame: 6 months
hemodynamics - Cardiac output (in l/min) in comparison to a historical patient group
6 months
oxygen consumption
Time Frame: 6 months
hemodynamics - Oxygen consumption (in l) in comparison to a historical patient group
6 months
respiration
Time Frame: 6 months
respiration- Maximum respiratory rate for 24h in comparison to a historical patient group
6 months
ICU Score - SOFA
Time Frame: 6 months
ICU Scores like Sepsis-related organ failure assessment score (SOFA) (0-24) in comparison to a historical patient group. A higher value means a worse outcome.
6 months
ICU Scores - APACHE II
Time Frame: 6 months
ICU Scores like Acute Physiology and Chronic Health Disease Classification System II (APACHE II) (0-71) in comparison to a historical patient group. A higher value means a worse outcome.
6 months
ICU Scores - SAPS II
Time Frame: 6 months
ICU Scores like Simplified Acute Physiology Score II (SAPS II) (0-163) in comparison to a historical patient group. A higher value means a worse outcome.
6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Michael Zoller, PD Dr., Ludwig-Maximilians - University of Munich
  • Principal Investigator: Inge Eberl, Prof. Dr., Catholic University of Eichstätt-Ingolstadt
  • Principal Investigator: Eduard Kraft, PD Dr., Ludwig-Maximilians - University of Munich
  • Principal Investigator: Uli Fischer, Dr., Ludwig-Maximilians - University of Munich

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 15, 2021

Primary Completion (Actual)

April 15, 2022

Study Completion (Actual)

May 15, 2022

Study Registration Dates

First Submitted

August 27, 2021

First Submitted That Met QC Criteria

September 27, 2021

First Posted (Actual)

October 8, 2021

Study Record Updates

Last Update Posted (Actual)

October 11, 2023

Last Update Submitted That Met QC Criteria

October 10, 2023

Last Verified

October 1, 2023

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Robotics

3
Subscribe